Search Within

Michael Forman Berger

Formats
  1. Meeting Abstract (431)
  2. Journal Article (332)
  3. Research Letter (9)
  4. Editorial (3)
  5. Guidelines (2)
  6. Review (2)
  7. Book Section (1)
  8. Conference Paper (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (781)
  2. Department of Pathology and Laboratory Medicine (781)
  3. GSK Faculty (781)
  4. Human Oncology and Pathogenesis Program (781)
  5. Department of Medicine (621)
  6. Solid Tumor Oncology Division (591)

More Groups

People
  1. David Solit (319)
  2. Marc Ladanyi (220)
  3. Ahmet Zehir (191)
  4. Maria Arcila (164)
  5. Nikolaus Schultz (162)
  6. Hikmat Al-Ahmadie (110)

More People

Years
  1. 2025 (31)
  2. 2024 (47)
  3. 2023 (55)
  4. 2022 (56)
  5. 2021 (40)
  6. 2020 (47)

More Years

Publications
  1. Journal of Clinical Oncology (156)
  2. Cancer Research (67)
  3. Modern Pathology (65)
  4. Clinical Cancer Research (55)
  5. Laboratory Investigation (52)
  6. Journal of Molecular Diagnostics (38)

More Publications

Publishers
  1. American Society of Clinical Oncology (179)
  2. American Association for Cancer Research (150)
  3. Nature Publishing Group (111)
  4. Nature Research (68)
  5. Elsevier Science, Inc. (47)
  6. Oxford University Press (41)

More Publishers

Results (781)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular signature of response to pazopanib salvage therapy for urothelial carcinoma
    Journal Article

    Pinciroli, P.; Won, H.; Iyer, G.; Canevari, S.; Colecchia, M.; Giannatempo, P.; Raggi, D.; Pierotti, M. A.; De Braud, F. G.; Solit, D. B.; more...
    Clinical Genitourinary Cancer (2016)

    Fulltext@MSK | Save
  • Somatic mutations in leukocytes infiltrating primary breast cancers
    Journal Article

    Kleppe, M.; Comen, E.; Wen, H. Y.; Bastian, L.; Blum, B.; Rapaport, F. T.; Keller, M.; Granot, Z.; Socci, N.; Viale, A.; more...
    npj Breast Cancer (2015)

    Fulltext@MSK | Save
  • Deleterious alterations in DNA damage response genes are associated with improved outcome in muscle-invasive bladder cancer patients treated with radiation-based bladder preservation
    Meeting Abstract

    Desai, N. B.; Iyer, G. I.; Cha, E. K.; Scott, S. N.; Hreiki, J.; Sfakianos, J.; Bagrodia, A.; Bochner, B. H.; Rosenberg, J. E.; Bajorin, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2015)

    Fulltext@MSK | Save
  • Clinical tumor sequencing: Opportunities and challenges for precision cancer medicine
    Journal Article

    Damodaran, S.; Berger, M. F.; Roychowdhury, S.
    American Society of Clinical Oncology Educational Book (2015)

    Fulltext@MSK | Save
  • Basaloid squamous cell cancers arising from the lung: Next generation sequencing reveals PTCH1 mutations in the hedgehog pathway
    Meeting Abstract

    Li, B. T.; Rekhtman, N.; Won, H.; Arcila, M. E.; Rudin, C. M.; Kris, M. G.; Berger, M.; Paik, P.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Clinically adoption of MSK-IMPACT, a hybridization capture-based next generation sequencing assay, for the assessment of lung adenocarcinomas
    Meeting Abstract

    Arcila, M. E.; Zehir, A.; Yu, H.; Drilon, A.; Li, B. T.; Riely, G. J.; Rekhtman, N.; Lin, O.; Hyman, D.; Berger, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Comprehensive mutation analysis of never-smokers with small cell lung cancer (SCLC)
    Meeting Abstract

    Pietanza, M. C.; Won, H.; Krug, L. M.; Varghese, A. M.; Riely, G. J.; Rekhtman, N.; Wang, L.; Travis, W. D.; Zakowski, M.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Response to MET inhibitors in stage IV lung adenocarcinoma patients with mutations that cause MET exon 14 skipping
    Meeting Abstract

    Paik, P.; Drilon, A.; Yu, H.; Rekhtman, N.; Borsu, L.; Ginsberg, M.; Berger, M.; Ladanyi, M.; Rudin, C. M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Examining the genomic differences between upper and lower tract urothelial carcinomas
    Meeting Abstract

    Scott, S. N.; Sfakianos, J. P.; Cha, E. K.; Iyer, G.; Zabor, E. C.; Kim, P. H.; Hakimi, A. A.; Ostrovnaya, I.; Ramirez, R.; Hanrahan, A. J.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save